These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 6142671

  • 41. Hypersensitivity reaction to sulfasalazine: skin rash, fever, hepatitis and activated lymphocytes.
    Leroux JL, Ghezail M, Chertok P, Blotman F.
    Clin Exp Rheumatol; 1992; 10(4):427. PubMed ID: 1356682
    [No Abstract] [Full Text] [Related]

  • 42. Salazopyrin and its newer analogues in the treatment of inflammatory bowel disease.
    Banatwala N.
    J Pak Med Assoc; 1985 Mar; 35(3):64-8. PubMed ID: 2860256
    [No Abstract] [Full Text] [Related]

  • 43. Slow lenalidomide desensitization protocol for patients with multiple myeloma: case series from a single center.
    Yau P, Jimenez-Zepeda VH, Bailey K, Duggan P, Tay J, Bahlis NJ, Neri P, McCulloch S.
    Leuk Lymphoma; 2019 Dec; 60(13):3199-3203. PubMed ID: 31190585
    [Abstract] [Full Text] [Related]

  • 44. Toxic epidermal necrolysis, agranulocytosis and erythroid hypoplasia associated with sulphasalazine.
    Maddocks JL, Slater DN.
    J R Soc Med; 1980 Aug; 73(8):587-8. PubMed ID: 6112274
    [No Abstract] [Full Text] [Related]

  • 45. Mild ulcerative colitis.
    Maitra AK.
    Br Med J; 1970 Feb 14; 1(5693):431. PubMed ID: 4392199
    [No Abstract] [Full Text] [Related]

  • 46. Sulfasalazine: I. An historical perspective.
    Bachrach WH.
    Am J Gastroenterol; 1988 May 14; 83(5):487-96. PubMed ID: 2896458
    [No Abstract] [Full Text] [Related]

  • 47. [Sulfasalazine allergy: fever, skin rash, hepatitis and T-lymphocytes].
    Gyssens IC, de Bock RF, Peetermans ME.
    Ned Tijdschr Geneeskd; 1989 Aug 12; 133(32):1608-10. PubMed ID: 2571950
    [Abstract] [Full Text] [Related]

  • 48. [Exacerbation of ulcerative colitis and Crohn disease as a phenomenon inherent in the disease].
    Habs M, Schifmann R.
    Dtsch Med Wochenschr; 1986 Jul 11; 111(28-29):1131. PubMed ID: 2874004
    [No Abstract] [Full Text] [Related]

  • 49. Sulfasalazine-induced pericarditis in a patient with ulcerative colitis without recurrence when switching to mesalazine.
    Perrot S, Aslangul E, Szwebel T, Gadhoum H, Romnicianu S, Le Jeunne C.
    Int J Colorectal Dis; 2007 Sep 11; 22(9):1119-21. PubMed ID: 17440739
    [Abstract] [Full Text] [Related]

  • 50. [Salozosulphapyridine and its metabolites in ulcerative colitis and Crohn disease].
    Rubinstein BE.
    Ugeskr Laeger; 1982 Feb 01; 144(5):304-6. PubMed ID: 6122297
    [No Abstract] [Full Text] [Related]

  • 51. Incidence of sulphasalazine-induced male infertility.
    Birnie GG, McLeod TI, Watkinson G.
    Gut; 1981 Jun 01; 22(6):452-5. PubMed ID: 6114898
    [Abstract] [Full Text] [Related]

  • 52. [Azulfidine/Salazopyrin therapy during pregnancy].
    Fahrländer H.
    Z Gastroenterol Verh; 1981 Jun 01; 19():24-6. PubMed ID: 6168128
    [No Abstract] [Full Text] [Related]

  • 53. The safety of sulfasalazine: the gastroenterologists' experience.
    Sachar DB.
    J Rheumatol Suppl; 1988 Sep 01; 16():14-6. PubMed ID: 2903923
    [Abstract] [Full Text] [Related]

  • 54. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine.
    Habal FM, Greenberg GR.
    Am J Gastroenterol; 1988 Jan 01; 83(1):15-9. PubMed ID: 2892391
    [Abstract] [Full Text] [Related]

  • 55. Sulfasalazine-induced lupus syndrome in a patient with Crohn's disease.
    Carr-Locke DL.
    Am J Gastroenterol; 1982 Sep 01; 77(9):614-6. PubMed ID: 6126117
    [Abstract] [Full Text] [Related]

  • 56. Pentasa in lieu of sulfasalazine.
    Mulder CJ, Tytgat GN, Dekker W, Terpstra IJ.
    Ann Intern Med; 1988 Jun 01; 108(6):911-2. PubMed ID: 2897181
    [No Abstract] [Full Text] [Related]

  • 57. [Therapeutic efficacy of 5-ASA molecules in idiopathic intestinal inflammatory diseases: critical review].
    Van Gossum A.
    Acta Gastroenterol Belg; 1992 Jun 01; 55(5-6):462-71. PubMed ID: 1363167
    [Abstract] [Full Text] [Related]

  • 58. [Treatment of chronic inflammatory intestinal diseases with 5-aminosalicylic acid].
    Malchow H.
    Internist (Berl); 1987 Jan 01; 28(1):14-20. PubMed ID: 2883152
    [No Abstract] [Full Text] [Related]

  • 59. Stevens-Johnson syndrome with sulfasalazine treatment: report of two cases.
    Tremblay L, Pineton de Chambrun G, De Vroey B, Lavogiez C, Delaporte E, Colombel JF, Cortot A.
    J Crohns Colitis; 2011 Oct 01; 5(5):457-60. PubMed ID: 21939920
    [Abstract] [Full Text] [Related]

  • 60. Sulfasalazine-induced lupus erythematosus.
    Clementz GL, Dolin BJ.
    Am J Med; 1988 Mar 01; 84(3 Pt 1):535-8. PubMed ID: 2894766
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.